These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 19799860)

  • 1. Generation of neutralizing monoclonal antibodies against Enterovirus 71 using synthetic peptides.
    Li X; Mao C; Ma S; Wang X; Sun Z; Yi Y; Guo M; Shen X; Sun L; Bi S
    Biochem Biophys Res Commun; 2009 Dec; 390(4):1126-8. PubMed ID: 19799860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of neutralizing linear epitopes from the VP1 capsid protein of Enterovirus 71 using synthetic peptides.
    Foo DG; Alonso S; Phoon MC; Ramachandran NP; Chow VT; Poh CL
    Virus Res; 2007 Apr; 125(1):61-8. PubMed ID: 17222936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and characterization of a cross-neutralization epitope of Enterovirus 71.
    Liu CC; Chou AH; Lien SP; Lin HY; Liu SJ; Chang JY; Guo MS; Chow YH; Yang WS; Chang KH; Sia C; Chong P
    Vaccine; 2011 Jun; 29(26):4362-72. PubMed ID: 21501643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of VP1 protein in the milk of transgenic mice: a potential oral vaccine protects against enterovirus 71 infection.
    Chen HL; Huang JY; Chu TW; Tsai TC; Hung CM; Lin CC; Liu FC; Wang LC; Chen YJ; Lin MF; Chen CM
    Vaccine; 2008 Jun; 26(23):2882-9. PubMed ID: 18450335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigenicity, animal protective effect and genetic characteristics of candidate vaccine strains of enterovirus 71.
    Mao Q; Li N; Yu X; Yao X; Li F; Lu F; Zhuang H; Liang Z; Wang J
    Arch Virol; 2012 Jan; 157(1):37-41. PubMed ID: 21984267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of monovalent and bivalent vaccines against lethal Enterovirus 71 and Coxsackievirus A16 infection in newborn mice.
    Sun S; Jiang L; Liang Z; Mao Q; Su W; Zhang H; Li X; Jin J; Xu L; Zhao D; Fan P; An D; Yang P; Lu J; Lv X; Sun B; Xu F; Kong W; Jiang C
    Hum Vaccin Immunother; 2014; 10(10):2885-95. PubMed ID: 25483672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of protective immune responses against EV71 in mice by baculovirus encoding a novel expression cassette for capsid protein VP1.
    Premanand B; Kiener TK; Meng T; Tan YR; Jia Q; Chow VT; Kwang J
    Antiviral Res; 2012 Sep; 95(3):311-5. PubMed ID: 22691220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined peptides of human enterovirus 71 protect against virus infection in mice.
    Liu JN; Wang W; Duo JY; Hao Y; Ma CM; Li WB; Lin SZ; Gao XZ; Liu XL; Xu YF; Xu WB; Qin C; Zhang LF
    Vaccine; 2010 Oct; 28(46):7444-51. PubMed ID: 20831911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishing China's national standards of antigen content and neutralizing antibody responses for evaluation of enterovirus 71 (EV71) vaccines.
    Liang Z; Mao Q; Gao Q; Li X; Dong C; Yu X; Yao X; Li F; Yin W; Li Q; Shen X; Wang J
    Vaccine; 2011 Dec; 29(52):9668-74. PubMed ID: 22015395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of a monoclonal antibody against the 3D polymerase of enterovirus 71 and its use for the detection of human enterovirus A infection.
    Kiener TK; Lim XF; Jia Q; Meng T; Chow VT; Kwang J
    J Virol Methods; 2012 Mar; 180(1-2):75-83. PubMed ID: 22226793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel inactivated enterovirus 71 vaccine can elicit cross-protective immunity against coxsackievirus A16 in mice.
    Yang L; Liu Y; Li S; Zhao H; Lin Q; Yu H; Huang X; Zheng Q; Cheng T; Xia N
    Vaccine; 2016 Nov; 34(48):5938-5945. PubMed ID: 27771182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal Structures of Yeast-Produced Enterovirus 71 and Enterovirus 71/Coxsackievirus A16 Chimeric Virus-Like Particles Provide the Structural Basis for Novel Vaccine Design against Hand-Foot-and-Mouth Disease.
    Lyu K; He YL; Li HY; Chen R
    J Virol; 2015 Jun; 89(12):6196-208. PubMed ID: 25833050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mechanism of intravenous immunoglobulin therapy for severe hand-foot-mouth disease: a review].
    Cao R; Han J; Qin E; Qin C
    Sheng Wu Gong Cheng Xue Bao; 2011 May; 27(5):712-6. PubMed ID: 21845837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of murine monoclonal antibodies with potent neutralization effects on enterovirus 71.
    Ku Z; Shi J; Liu Q; Huang Z
    J Virol Methods; 2012 Dec; 186(1-2):193-7. PubMed ID: 22771741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a high-throughput assay for measuring serum neutralizing antibody against enterovirus 71.
    Huang ML; Chiang PS; Luo ST; Liou GY; Lee MS
    J Virol Methods; 2010 Apr; 165(1):42-5. PubMed ID: 20036286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation and characterization of a protective mouse monoclonal antibody against human enterovirus 71.
    Deng YQ; Ma J; Xu LJ; Li YX; Zhao H; Han JF; Tao J; Li XF; Zhu SY; Qin ED; Qin CF
    Appl Microbiol Biotechnol; 2015 Sep; 99(18):7663-71. PubMed ID: 25967656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EV71 virus-like particles produced by co-expression of capsid proteins in yeast cells elicit humoral protective response against EV71 lethal challenge.
    Wang X; Xiao X; Zhao M; Liu W; Pang L; Sun X; Cen S; Yang BB; Huang Y; Sheng W; Zeng Y
    BMC Res Notes; 2016 Jan; 9():42. PubMed ID: 26809443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EV71: an emerging infectious disease vaccine target in the Far East?
    Xu J; Qian Y; Wang S; Serrano JM; Li W; Huang Z; Lu S
    Vaccine; 2010 Apr; 28(20):3516-21. PubMed ID: 20304038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of a high-titered antibody response using HIV gag-EV71 VP1-based virus-like particles with the capacity to protect newborn mice challenged with a lethal dose of enterovirus 71.
    Wang X; Dong K; Long M; Lin F; Gao Z; Wang L; Zhang Z; Chen X; Dai Y; Wang H; Zhang H
    Arch Virol; 2018 Jul; 163(7):1851-1861. PubMed ID: 29582164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A combination vaccine comprising of inactivated enterovirus 71 and coxsackievirus A16 elicits balanced protective immunity against both viruses.
    Cai Y; Ku Z; Liu Q; Leng Q; Huang Z
    Vaccine; 2014 May; 32(21):2406-12. PubMed ID: 24657161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.